Statistics from Altmetric.com
Alcohol withdrawal syndrome
Alcohol withdrawal syndrome (AWS) can be a life-threatening condition affecting some alcohol-dependent patients who abruptly discontinue or decrease their alcohol consumption. At present, benzodiazepines (BZDs) are the drugs of choice in the treatment of AWS1, as they have proven their efficacy in ameliorating symptoms and decreasing the risk of seizures and delirium tremens.2 However, the use of BZDs may be associated with increased risk of excess sedation, memory deficits and respiratory depression.1 BZDs also have abuse and dependence liability4 which constitutes a limitation to their use in patients affected by substance-abuse disorder.1 Thus, in recent years, there has been a growing interest in testing non-BZD GABAergic medications in the treatment of AWS.4 Ideally, a pharmacotherapy for AWS should have …
Competing interests None.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.